BRS2(FM1) - Methylation Cycle Efficiency

(One-Carbon Methylation & Homocysteine Recycling)

Primary Mechanisms

• BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation
• BRS2-FM1-PM2 — Betaine/BHMT Remethylation
• BRS2-FM1-PM3 — SAMe Synthesis
• BRS2-FM1-PM4 — Methionine Cycle Flux

Key Constraints

• BRS2(KC1) — Methyl Donor Pool

The following are independently admitted child-PM connections. They do not establish a uniform constraint on the whole FM or benefit from increasing intake.

PM	Accepted connection	Evidence and boundary
BRS2-FM1-PM1	Supported upstream supply: The folate member of KC1 supplies folate forms converted to 5-methyltetrahydrofolate for PM1 methionine synthase.	This is the folate provision relationship already disclosed on PM1, not a new reaction or proof of a limiting effect on tissue flux. Functional B12 is required. Betaine and choline support a parallel BHMT route, not this enzyme’s donor reaction. Froese et al. (2019) [9]
BRS2-FM1-PM2	Conditional constraint: KC1’s betaine/choline route supplies BHMT methyl donor; demonstrated choline depletion can reduce remethylation reserve under a methionine challenge.	Human evidence is an eight-man depletion pilot, with the challenge response in four clinically depleted participants; tissue BHMT flux was not measured. Rat donor rescue and specific inhibition support the chain. This does not establish ordinary-diet limitation, response in every tissue or benefit above adequacy. Folate’s indirect constraint on BHMT remains unresolved. Evans et al. (2002) [1]; Salvi and Gadda (2013) [4]; da Costa et al. (2005) [6]; Setoue et al. (2008) [12]; Strakova et al. (2011) [13]
BRS2-FM1-PM3	Supported upstream supply: KC1 contributes methyl groups to methionine regeneration through PM1 — Folate/B12-dependent remethylation and PM2 — Betaine/BHMT remethylation. PM3 uses that regenerated methionine to produce SAMe.	Deficiency and pathway-impairment studies support this upstream connection, with responses varying by tissue and condition. KC1’s limiting effect on MAT-dependent synthesis remains unresolved; SAMe abundance also reflects consumption and turnover. Benefit from additional intake in nutrient-replete individuals is not established. This pool relationship is distinct from PM3’s biochemical reaction requirements. Froese et al. (2019) [7]; Obeid (2013) [8]; Evans et al. (2002) [9]; Salvi and Gadda (2013) [10]
BRS2-FM1-PM4	Supported upstream supply: KC1’s folate and betaine routes replenish methionine within the integrated cycle; choline supplies the betaine route.	BHMT is mainly hepatic/renal and alternative methionine supply can compensate. The supported routes do not show that donor availability limits net cycle rates or the remethylation–transsulfuration split. Homocysteine concentration is not branch flux. Froese et al. (2019) [15]; Obeid (2013) [17]; Evans et al. (2002) [18]; Salvi and Gadda (2013) [19]; Finkelstein (1998) [12]

1. Mission & Overview

Mission

Maintain coordinated one-carbon cycling that supports homocysteine remethylation, SAMe production, and methyl-group transfer.

Overview

Coordinates folate/B12- and betaine-dependent homocysteine remethylation with methionine-cycle flux and SAMe production. This integrated state maintains methyl-donor availability for phospholipid, neurotransmitter, and other methylation-dependent chemistry across the brain and body.

• Maintains methyl-donor context for neurotransmitter-related chemistry — Supporting BRS1.
• Connects homocysteine handling with transsulfuration and redox pathways — within BRS2 and Supporting BRS3.
• Supplies SAMe-dependent methyl-group transfer used across cellular metabolism — Supporting BRS4.

2. Primary Biological Effects

Methionine regeneration; SAMe production; homocysteine handling; methyl-group transfer.

4. Mechanistic Basis (Integrated FM Narrative)

4.1 Functional Rationale

Remethylation, SAMe formation and regulated cycle routing maintain methyl-transfer capacity while handling homocysteine. Their coordination provides a biological basis for methylation-dependent functions without defining a universal optimum for metabolite concentrations.

4.2 Evidence Summary

Human enzyme studies establish distinct folate/B12, betaine and MAT reaction requirements. Choline-depletion challenge evidence supports a bounded upstream dependency. Human tracer measurements found unchanged mean cycle rates during moderate vitamin B6 restriction despite altered PLP and cystathionine concentrations. [10, 11, 12, 13, 14]

Together, functioning provision and routing capacities would support methionine regeneration and SAMe-dependent methyl transfer. This is a synthesis of complementary pathway evidence, not proof that lowering blood homocysteine increases tissue methylation or improves cognition.

4.3 Suboptimal Function & Its Effects

Effects depend on the affected route and nutritional context. In the choline-depletion study, the four clinically depleted men had reduced homocysteine-handling reserve after a methionine challenge; this does not establish the same impairment in adequately nourished people or measure human BHMT flux. [13]

The accepted child-PM connections distinguish this conditional PM2 constraint from supported supply in PM1, PM3 and PM4. Whether donor availability limits tissue MTR capacity, MAT-dependent synthesis or integrated cycle rates remains unresolved. A change in homocysteine or SAMe concentration alone cannot establish a cascade of impaired synthesis, routing and methylation across all four PMs. [12, 14]

5. Connected Mechanisms

• BRS1-FM2-PM6 — Acetylcholine Synthesis Support — Shares the choline resource with methyl-donor provision. Animal folate/methionine-cycle impairment studies report altered brain choline and acetylcholine; they do not establish donor-intake control of acetylcholine synthesis in adequately nourished humans. [15, 16, 17]
• BRS1-FM3-PM7 — Neuronal Membrane DHA Incorporation — Choline supports phosphatidylcholine production through the Kennedy pathway, connecting nutritional provision with DHA-carrier biology. Separately, choline can contribute methyl groups through betaine and SAMe to the PEMT route. Whether inadequate choline or methyl-donor supply limits adult brain DHA incorporation remains unresolved and context-dependent; these supported pathways do not establish benefit from additional intake. [18, 20, 21, 22]
• BRS2-FM2-PM5 — Transsulfuration Pathway — Uses homocysteine at the cycle's transsulfuration exit: CBS joins it with serine to form cystathionine. This shares an intermediate with remethylation, without making homocysteine concentration a measure of either branch's flux. [19]
• BRS2-FM3-PM7 — Phosphatidylcholine Formation — Uses SAMe as the methyl donor for PEMT-mediated conversion of phosphatidylethanolamine to phosphatidylcholine. Supply of the donor does not establish increased PEMT activity or phosphatidylcholine output. [20]
• BRS2(FM3) — Methylation–Membrane Coupling — Connects this FM's SAMe-producing metabolism with the SAMe-dependent phospholipid chemistry assessed in its PEMT child. This is shared reaction-resource context, not a demonstrated improvement in brain delivery or cognition. [20]

7. Phenome Connections

These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.

Cognitive ClarityOpen Page →→

Focus / Attention StabilityOpen Page →→

8. References

• [1] Collaboration (1998) — Lowering Blood Homocysteine with Folic Acid Based Supplements
• [2] Tao Huang et al. (2015) — A Randomized Controlled Trial
• [3] Oulhaj et al. (2016) — Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B
• [4] Luzzi et al. (2022) — State of the Art
• [5] Chiang et al. (1996) — S-Adenosylmethionine and Methylation
• [6] Razavinia et al. (2024) — Vitamins B ₉ and B ₁₂ in Children with Attention Deficit Hyperactivity
• [7] Lukovac et al. (2024) — Implications of Homocysteine, Vitamin B12, Vitamin D, Ferritin, and Iron Levels
• [8] Wang et al. (2019) — Path Analysis for a Case-Control Study
• [9] Millichap and Yee (2012) — Diet Factor in Attention-Deficit/Hyperactivity Disorder
• [10] Froese et al. (2019) — Vitamin B12, folate and methionine remethylation
• [11] Evans et al. (2002) — Human BHMT structure and catalytic zinc
• [12] Bailey et al. (2021) — Human MAT2A ordered kinetic mechanism
• [13] da Costa et al. (2005) — Choline depletion and post-load homocysteine
• [14] Lamers et al. (2011) — Vitamin B6 restriction and methionine-cycle rates
• [15] Chan et al. (2008) — Folate–SAM Constraint on Brain Choline and Acetylcholine
• [16] Crivello et al. (2010) — Folate Deficiency Alters Regional Choline and Acetylcholine
• [17] Jadavji et al. (2014) — Methionine-Cycle Deficiency Disturbs Brain Choline Metabolism
• [18] Patrick (2019) — Role of Phosphatidylcholine-DHA in Preventing APOE4-associated Alzheimer's Disease
• [19] Belew et al. (2009) — Human CBS kinetics with serine and homocysteine
• [20] Vance (2014) — Physiological Roles of Phosphatidylethanolamine N-methyltransferase
• [21] Derbyshire and Maes (2023) — Choline in Neurodevelopmental Disorders
• [22] Derbyshire (2019) — Could We Be Overlooking a Potential Choline Crisis in the United Kingdom?